On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT(1A) antagonist, WAY 100635

Psychopharmacology

Volumn 132, Issue 1, 1997, Pages 35-43

  Collinson, N ^a   Dawson, G R ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

5 HT(1A); 8 OH DPAT; Anxiogenic; Anxiolytic; Buspirone; CNS; Elevated plus maze; Rats; WAY 100635

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ANXIOGENIC AGENT; ANXIOLYTIC AGENT; BUSPIRONE; CHLORDIAZEPOXIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; PARTIAL AGONIST; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TRANQUILIZING ACTIVITY;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANXIETY; BUSPIRONE; EXPLORATORY BEHAVIOR; MALE; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGENTS;

EID: 0030741653     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050317     Document Type: Article

References (22)

1. 2 receptors. Psychopharmacology 93:502 506
2. Dawson GR, Crawford SP, Collinson N, Iversen SD, Tricklebank MD (1995) Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus-maze are confounded by increases in locomotor activity. Psychopharmacology 118: 316-323
3. 1A receptor agonists : recent developments and controversial issues. Psychopharmacology 121:1-26
4. 1A receptors in anxiety. In: Briley M, File SE (eds) New concepts in anxiety. Macmillan Press, London, pp 94-129
5. Dorow R, Horowski R, Paschelke G, Amin M, Braestrup C (1983) Severe anxiety induced by FG 7142, a β-carboline ligand for benzodiazepine receptors. Lancet 9:98-99
6. 1A receptors. Ellis Horwood, Chichester, pp 261-277
7. 1A receptor antagonist, WAY-100635. Eur J Pharmacol 281 :81-88
8. Goldberg HL, Finnerty RJ (1979) The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am J Psychiatry 136: 1184-1187
9. Handley SL (1991) Serotonin in animal models of anxiety: the importance of stimulus and response. In: Idzikowski C, Cowen PJ (eds) Serotonin, sleep and mental disorder. Wrightson Biomedical Publishing, Petersfield, pp 89-115
10. Handley SL, McBlane JW (1993a) An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs. J Pharmacol Toxicol Meth 29: 129-138
11. Handley SL, McBlane JW (1993b) 5-HT drugs in animal models of anxiety. Psychopharmacology 112: 13-20
12. Handley SL, McBlane JW, Critchley MAE, Njung'e K (1993) Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors. Behav Brain Res 58:203-210
13. Hutson PH, Dourish CT, Curzon G (1986) Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors. Eur J Pharmacol 129: 347-352
14. Klint T (1991) Effects of 8-OH-DPAT and buspirone in a passive avoidance test and in the elevated plus-maze test in rats. Behav Pharmacol 2: 481-489
15. 1A ligand BP 554 mimics the anxiolytic activity of buspirone, gepirone and ipsapirone in the elevated plus-maze in rats. Br J Pharmacol 105:130P
16. 1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT. Psychopharmacology 125: 89-91
17. 1A agonists on locomotor and investigatory behaviours in rats differ from those of hallucinogens. Psychopharmacology 98: 321-329
18. Moser PC (1989) An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacology 99:48-53
19. Pellow S, Johnston AL, File SE (1987) Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze in the rat. J Pharm Pharmacol 39:917-928
20. Redfern WS, Williams A (1989) Acute effects of centrally acting drugs on the behaviour of rats in the elevated X-maze and a partially-shaded holeboard. Br J Pharmacol 97:9P
21. Sathananthan GL, Sanghui I, Phillips N, Gershon S (1975) MJ 9022: correlation between neuroleptic potential and stereotypy. Curr Ther Res 18:701-705
22. 1A receptor agonists and L-5-HTP in Montgomery's conflict test. Pharmacol Biochem Behav 32: 259-265